Jessica Ailani, MD

June 16, 2022

Although new treatments and innovations are a sign of growth in migraine care, it is important to realize that growth comes with a certain amount of pain. In clinical practice, choosing the right treatment option for patients in a time-limited visit is often a dilemma.

June 01, 2022

Bradley Torphy, MD, and Julio R. Vieira, MD, share unmet needs and clinical pearls for the management of migraine.

June 01, 2022

Experts in headache medicine review novel therapeutic agents under investigation and the evolving treatment landscape for migraine.

May 25, 2022

Julio R. Vieira, MD, leads a discussion on the importance of follow-up visits for patients with migraine and considerations for switching therapies.

May 25, 2022

Andrew C. Charles, MD; Bradley Torphy, MD; and Jessica Ailani, MD, review current FDA approved CGRP monoclonal antibodies available for the preventive treatment of migraine.

May 18, 2022

Experts in headache medicine discuss the role of CGRP-based therapy for migraine prevention.

May 18, 2022

Drs Bradley Torphy and Jessica Ailani share thoughts on using consensus statements to guide the treatment of migraine.

May 10, 2022

Sait Ashina, MD, reviews current AHS (American Headache Society) treatment recommendations for the acute and preventive treatment of migraine.

May 10, 2022

Dr Julio R. Vieira defines acute versus preventive treatment for migraine and highlights the differences in goals of therapy for each.

May 03, 2022

Sait Ashina, MD, and Jessica Ailani, MD, comment on the importance of individualized treatment regimens for the management of migraine.